Moderna
MRNA
#1082
Rank
NZ$30.11 B
Marketcap
$78.26
Share price
-6.86%
Change (1 day)
-33.69%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: NZ$30.11 Billion

As of November 2024 Moderna has a market cap of NZ$30.11 Billion. This makes Moderna the world's 1082th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$30.11 B-49.77%
2023NZ$59.95 B-44.83%
2022NZ$108.68 B-27.91%
2021NZ$150.76 B163.14%
2020NZ$57.29 B486.18%
2019NZ$9.77 B30.58%
2018NZ$7.48 B

End of Day market cap according to different sources

On Nov 9th, 2024 the market cap of Moderna was reported to be:

NZ$30.11 Billion
by Yahoo Finance info icon info icon
NZ$30.11 Billion
by CompaniesMarketCap info icon info icon
NZ$30.08 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$0.16 B-99.47%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$435.09 B 1,344.70%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.39 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$59.80 B 98.56%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$355.66 B 1,080.97%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$4.54 B-84.90%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$625.55 B 1,977.09%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$4.97 B-83.48%๐Ÿ‡บ๐Ÿ‡ธ USA